TUBA1B作为一种与免疫抑制性瘤微环境和免疫治疗反应相关的新型预后生物标志物
Juntao Qi1,2, Mingming Zhou3, Na Yang4
1Rehabilitation Medicine Department, Hunan Aerospace Hospital, Hunan Normal University, Changsha, Hunan, China.
Frontiers in pharmacology
|February 19, 2025
概括
素α1b (TUBA1B) 是细胞结构中的一个关键蛋白质. 这项研究揭示了TUBA1B驱动癌症的进展,并创造了一个免疫抑制瘤微环境,建议它作为改善癌症治疗结果的治疗标.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 免疫学 免疫学 免疫学
背景情况:
- 素α1b (TUBA1B) 是细胞结构和功能至关重要的微管蛋白.
- 它在癌症预后和各种癌症类型的瘤免疫微环境中的特定作用尚未得到充分定义.
研究的目的:
- 综合分析TUBA1B在癌症患者生存中的作用及其对瘤免疫微环境的影响.
- 研究TUBA1B对瘤细胞行为和免疫调节的功能影响.
主要方法:
- 综合分析了TCGA,GTEx,CCLE,人类蛋白质图谱,卡普兰-梅尔图谱,cBioPortal,TIMER和ImmuCellAI的多omics数据.
- 利用了大规模的临床和免疫疗法队列数据,以及体外功能测定,以评估TUBA1B的致癌和免疫调节功能.
主要成果:
- 在多种癌症中,TUBA1B表达显著失调,与生存率差和晚期相相关.
- 通过调节细胞循环过程,TUBA1B促进瘤的增殖,迁移和入侵.
- TUBA1B影响先天和适应性免疫功能,有助于免疫抑制瘤微环境.
结论:
- TUBA1B作为参与瘤发生和免疫调节的人类瘤基因.
- 增加的TUBA1B与免疫抑制性瘤微环境有关,对癌症的进展和治疗反应产生负面影响.
- 向TUBA1B为新型抗癌治疗提供了一个有前途的治疗策略.
相关概念视频
02:17The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
01:27Tumor Immunotherapy
463
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
463